129 related articles for article (PubMed ID: 38270193)
1. Distinguishing metabolic signals of liver tumors from surrounding liver cells using hyperpolarized
Agarwal S; Gordon J; Bok RA; von Morze C; Vigneron DB; Kurhanewicz J; Ohliger MA
Magn Reson Med; 2024 May; 91(5):2114-2125. PubMed ID: 38270193
[TBL] [Abstract][Full Text] [Related]
2. Combining hyperpolarized
Ohliger MA; von Morze C; Marco-Rius I; Gordon J; Larson PEZ; Bok R; Chen HY; Kurhanewicz J; Vigneron D
Magn Reson Med; 2017 Jun; 77(6):2356-2363. PubMed ID: 27298073
[TBL] [Abstract][Full Text] [Related]
3. Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.
Bashir MR; Breault SR; Braun R; Do RK; Nelson RC; Reeder SB
Acad Radiol; 2014 Jun; 21(6):726-32. PubMed ID: 24717550
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
Giraudeau C; Leporq B; Doblas S; Lagadec M; Pastor CM; Daire JL; Van Beers BE
Eur Radiol; 2017 May; 27(5):1804-1811. PubMed ID: 27553933
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
[TBL] [Abstract][Full Text] [Related]
6. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
[TBL] [Abstract][Full Text] [Related]
7. cDNA Microarray Analysis and Influx Transporter OATP1B1 in Liver Cells After Exposure to Gadoxetate Disodium, a Gadolinium-based Contrast Agent in MRI Liver Imaging.
Lu CC; Chen WK; Chiang JH; Tsai YF; Juan YN; Lin PC; Tyan YS; Yang JS
In Vivo; 2018; 32(3):677-684. PubMed ID: 29695578
[TBL] [Abstract][Full Text] [Related]
8. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging.
Okada M; Imai Y; Kim T; Kogita S; Takamura M; Kumano S; Onishi H; Hori M; Fukuda K; Hayashi N; Wakasa K; Sakamoto M; Murakami T
J Magn Reson Imaging; 2010 Oct; 32(4):903-13. PubMed ID: 20882621
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.
Kim SY; Wu EH; Park SH; Wang ZJ; Hope TA; Yee J; Zhao LQ; Chang WC; Yeh BM
Abdom Radiol (NY); 2016 Aug; 41(8):1522-31. PubMed ID: 26971341
[TBL] [Abstract][Full Text] [Related]
10. Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma.
Schalkx HJ; van Stralen M; Coenegrachts K; van den Bosch MA; van Kessel CS; van Hillegersberg R; van Erpecum KJ; Verkooijen HM; Pluim JP; Veldhuis WB; van Leeuwen MS
Eur Radiol; 2014 Sep; 24(9):2146-56. PubMed ID: 24996795
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study.
Froehlich JM; Moussa L; Guirguis N; Gutzeit A; Wu D; Sartoretti-Schefer S; Koh DM; Kolokythas O; Matoori S
Eur Radiol Exp; 2023 Apr; 7(1):21. PubMed ID: 37093398
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
Rong D; He B; Tang W; Xie S; Kuang S; Grazioli L; Hussain SM; Yang Y; Wang J
AJR Am J Roentgenol; 2022 Apr; 218(4):687-698. PubMed ID: 34817191
[No Abstract] [Full Text] [Related]
14. Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?
Pahade JK; Juice D; Staib L; Israel G; Cornfeld D; Mitchell K; Weinreb J
Abdom Radiol (NY); 2016 Jul; 41(7):1270-84. PubMed ID: 26800701
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application.
Holesta M; Weichet J; Wagnerova MG; Lukavsky J; Malikova H
Neurol India; 2018; 66(6):1771-1775. PubMed ID: 30504579
[TBL] [Abstract][Full Text] [Related]
16. Non-focal liver signal abnormalities on hepatobiliary phase of gadoxetate disodium-enhanced MR imaging: a review and differential diagnosis.
Furlan A; Borhani AA; Heller MT; Yu RK; Tublin ME
Abdom Radiol (NY); 2016 Jul; 41(7):1399-410. PubMed ID: 26907715
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.
Kromrey ML; Hori M; Goshima S; Kozaka K; Hyodo T; Nakamura Y; Nishie A; Tamada T; Shimizu T; Kanki A; Motosugi U
Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655
[TBL] [Abstract][Full Text] [Related]
18. Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized
Dou Q; Grant AK; Coutinto de Souza P; Moussa M; Nasser I; Ahmed M; Tsai LL
Radiol Imaging Cancer; 2024 Mar; 6(2):e230056. PubMed ID: 38426887
[TBL] [Abstract][Full Text] [Related]
19. GADOXETATE DISODIUM (GD-EOB-DTPA) CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA IN DOGS.
Constant C; Hecht S; Craig LE; Lux CN; Cannon CM; Conklin GA
Vet Radiol Ultrasound; 2016 Nov; 57(6):594-600. PubMed ID: 27633531
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
